180 related articles for article (PubMed ID: 26218765)
21. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
[TBL] [Abstract][Full Text] [Related]
22. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
Brück A; Aalto S; Nurmi E; Bergman J; Rinne JO
Neurobiol Aging; 2005 Jun; 26(6):891-8. PubMed ID: 15718048
[TBL] [Abstract][Full Text] [Related]
23. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.
Lyoo CH; Ryu YH; Lee MS
Mov Disord; 2010 Mar; 25(4):496-9. PubMed ID: 20108369
[TBL] [Abstract][Full Text] [Related]
24. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
[TBL] [Abstract][Full Text] [Related]
25. Impulse control disorders and punding in Parkinson's disease: the need for a structured interview.
Ávila A; Cardona X; Bello J; Maho P; Sastre F; Martín-Baranera M
Neurologia; 2011 Apr; 26(3):166-72. PubMed ID: 21163239
[TBL] [Abstract][Full Text] [Related]
26. Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.
Tessitore A; Santangelo G; De Micco R; Vitale C; Giordano A; Raimo S; Corbo D; Amboni M; Barone P; Tedeschi G
Parkinsonism Relat Disord; 2016 Mar; 24():119-25. PubMed ID: 26810913
[TBL] [Abstract][Full Text] [Related]
27. Repetitive transcranial magnetic stimulation transiently reduces punding in Parkinson's disease: a preliminary study.
Nardone R; De Blasi P; Höller Y; Christova M; Tezzon F; Trinka E; Brigo F
J Neural Transm (Vienna); 2014; 121(3):267-74. PubMed ID: 24132699
[TBL] [Abstract][Full Text] [Related]
28. Punding and dyskinesias.
Silveira-Moriyama L; Evans AH; Katzenschlager R; Lees AJ
Mov Disord; 2006 Dec; 21(12):2214-7. PubMed ID: 17013916
[TBL] [Abstract][Full Text] [Related]
29. Patterns of cortical thickness and surface area in early Parkinson's disease.
Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O
Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830
[TBL] [Abstract][Full Text] [Related]
30. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
[TBL] [Abstract][Full Text] [Related]
31. Topographic pattern of cortical thinning with consideration of motor laterality in Parkinson disease.
Kim JS; Yang JJ; Lee JM; Youn J; Kim JM; Cho JW
Parkinsonism Relat Disord; 2014 Nov; 20(11):1186-90. PubMed ID: 25231669
[TBL] [Abstract][Full Text] [Related]
32. Imaging changes associated with cognitive abnormalities in Parkinson's disease.
Koshimori Y; Segura B; Christopher L; Lobaugh N; Duff-Canning S; Mizrahi R; Hamani C; Lang AE; Aminian K; Houle S; Strafella AP
Brain Struct Funct; 2015 Jul; 220(4):2249-61. PubMed ID: 24816399
[TBL] [Abstract][Full Text] [Related]
33. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.
Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G
Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
35. Progression of cortical thinning in early Parkinson's disease.
Ibarretxe-Bilbao N; Junque C; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Bargallo N; Tolosa E
Mov Disord; 2012 Dec; 27(14):1746-53. PubMed ID: 23124622
[TBL] [Abstract][Full Text] [Related]
36. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
[TBL] [Abstract][Full Text] [Related]
37. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.
Tu PC; Chen LF; Hsieh JC; Bai YM; Li CT; Su TP
Psychiatry Res; 2012 Jun; 202(3):206-13. PubMed ID: 22521631
[TBL] [Abstract][Full Text] [Related]
38. Retrosplenial cortical thinning as a possible major contributor for cognitive impairment in HIV patients.
Shin NY; Hong J; Choi JY; Lee SK; Lim SM; Yoon U
Eur Radiol; 2017 Nov; 27(11):4721-4729. PubMed ID: 28409354
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
[TBL] [Abstract][Full Text] [Related]
40. Predictors of punding in Parkinson's disease: results from a questionnaire survey.
Lawrence AJ; Blackwell AD; Barker RA; Spagnolo F; Clark L; Aitken MR; Sahakian BJ
Mov Disord; 2007 Dec; 22(16):2339-45. PubMed ID: 17914729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
